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Abstract
A tight control over AKT/PKB activation is essential for cells, and they realise this in part by regulating the phosphorylation
of Ser473 in the ‘‘hydrophobic motif’’ of the AKT carboxy-terminal region. The RICTOR-mTOR complex (TORC2) is a major
kinase for AKT Ser473 phosphorylation after stimulation by several growth factors, in a reaction proposed to require p21-
activated kinase (PAK) as a scaffold. However, other kinases may catalyse this reaction in stimuli-specific manners. Here we
characterised the requirement of RICTOR, ILK, and PAK for AKT Ser473 phosphorylation downstream of selected family
members of integrins, G protein-coupled receptors, and tyrosine-kinase receptors and analysed the importance of this
phosphorylation site for adhesion-mediated survival. siRNA-mediated knockdown in HeLa and MCF7 cells showed that
RICTOR-mTOR was required for phosphorylation of AKT Ser473, and for efficient phosphorylation of the downstream AKT
targets FOXO1 Thr24 and BAD Ser136, in response to b1 integrin-stimulation. ILK and PAK1/2 were dispensable for these
reactions. RICTOR knockdown increased the number of apoptotic MCF7 cells on b1 integrin ligands up to 2-fold after 24 h in
serum-free conditions. b1 integrin-stimulation induced phosphorylation of both AKT1 and AKT2 but markedly preferred
AKT2. RICTOR-mTOR was required also for LPA-induced AKT Ser473 phosphorylation in MCF7 cells, but, interestingly, not in
HeLa cells. PAK was needed for the AKT Ser473 phosphorylation in response to LPA and PDGF, but not to EGF. These results
demonstrate that different receptors utilise different enzyme complexes to phosphorylate AKT at Ser473, and that AKT
Ser473 phosphorylation significantly contributes to b1 integrin-mediated anchorage-dependent survival of cells.
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Introduction
Although various stimuli can generate anti-apoptotic signals in
cells, most cells are dependent on integrin-mediated adhesion for
their survival. Integrins are believed to protect against cell death,
mainly by the activation of AKT [1,2]. Since many growth factor
receptors, G protein-coupled receptors, and cytokine receptors
also efficiently induce AKT activation [3], the requirement for
anchorage is not obvious. Conceivably, it may be due to the more
persistent receptor-ligand interactions in focal contacts, or possibly
to a different regulation of AKT by integrins.
The activation of AKT family kinases (AKT1–3) involves
phosphorylation on Thr308 in the ‘‘activation loop’’ of the
catalytic domain and Ser473 in the C-terminal ‘‘hydrophobic
motif’’ (the phosphorylation sites are Thr308, Thr309, and
Thr305, and Ser473, Ser474, and Ser472 for AKT1–3, respec-
tively; for convenience, these sites are referred to as Thr308 and
Ser473 in this article). In addition to these phosphorylation sites
required for full AKT kinase activity [4,5,6], phosphorylation of
other AKT residues also contributes to AKT regulation [7,8]. The
role of phosphatidylinositol-3 kinase (PI3K) in the regulation and
activation of AKT became clear when 3-phosphoinositide-
dependent protein kinase-1 (PDK1) was identified as the activation
loop Thr308 kinase [4,9]. However, reaching a consensus on the
so-called PDK2 (the Ser473 kinase) has proved to be difficult.
More than ten different kinases have been proposed to act as
PDK2s [10]. The controversy about the physiological PDK2 has
mostly revolved around the role of integrin-linked kinase (ILK)
[11], DNA-dependent protein kinase (DNA-PK) [12], ataxia
telangiectasia mutated (ATM) [13], ataxia telangiectasia and rad-
3-related kinase (ATR) [14], protein kinase C (PKC) [15], and
RICTOR-mTOR (TORC2) [16].
DNA-PK, ATM and ATR are activated in response to DNA
damage, e.g. double-stranded DNA break, and may phosphorylate
AKT at Ser473 in such situations [12,13,14]. However, growth
factor-induced AKT Ser473 phosphorylation does not require
DNA-PK, ATM or ATR activity [10,17,18]. ILK was, in a
number of studies, implicated as a key regulator of the
physiological AKT activation. Using different molecular, bio-
chemical and cell-culture approaches, this protein has been shown
to bind AKT and to induce phosphorylation at Ser473 [11,19,20].
Still, others have seriously questioned the ability of this protein to
act as a kinase. ILK lacks some critical structural features
considered necessary for kinase activity [21] and its function
may be restricted to a role as an adaptor. However, in spite of the
atypical active site structure, a Mn
2+-dependent kinase activity was
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Fukuda et al. [23] has provided evidence against even this kinase
function proposed for ILK. Therefore, the role of ILK as a kinase
still remains controversial. In contrast to ILK, mTOR in complex
with RICTOR [16,24] and SIN1/MIP1 [25] has been clearly
shown to phosphorylate AKT at Ser473. Experiments with human
and drosophila cell lines, RICTOR-null mouse fibroblasts, as well
as in vivo experiments with RICTOR-deficient mice have
convincingly shown that TORC2 is a principal physiological
PDK2 [16,26,27]. However, these studies do not rule out the
possibility that other kinase(s) may act as the preferred PDK2 in a
context-dependent or cell type-specific manner [10,28,29], and
phosphorylation of AKT Ser473 was not completely eliminated in
RICTOR knockout mouse embryos [26]. Recent studies have
suggested that growth factor-induced membrane translocation and
activation of AKT requires a protein scaffold provided by p21-
activated kinase (PAK) [30]. Others have shown that PAK itself
can act as a PDK2 and that inhibition of PAK kinase activity
inhibits AKT Ser473 phosphorylation [28,31,32].
b1 integrins constitute a main group of cell adhesion receptors
to extracellular matrices. Whether ILK, TORC2 or another
enzyme is the primary AKT hydrophobic-motif Ser473 kinase
specifically downstream of b1 integrins has not been investigated,
and this is therefore an important open question. The role of PAK
in b1 integrin-induced AKT activation is also unknown. Other
central questions regarding the adhesion-dependent survival
signalling pathways are: Which AKT isoform(s) is activated by
b1 integrins? Is phosphorylation at the hydrophobic motif
required for cell survival?
Previously, we have reported differences between b1 integrin-
and growth factor-induced PI3K activation [33]. In this study, we
investigated the above-mentioned issues of b1 integrin-induced
AKT Ser473 phosphorylation. For this purpose, we used siRNAs
to knock down ILK, RICTOR-mTOR, or PAK1/PAK2 in HeLa
and MCF7 cells and studied the effect of their depletion on the
phosphorylation of AKT Ser473 in adhesion assays. To compare
the AKT activation-mechanisms utilised by members of major cell
surface receptor families in the same cellular context, we also
studied the involvement of these proteins in PDGF-, EGF- and
LPA-mediated AKT Ser473 phosphorylation. Our results identify
similarities as well as stimuli-specific differences in this pathway,
and demonstrate the importance of AKT Ser473 phosphorylation
for anchorage-dependent survival.
Results
b1 integrin-mediated regulation of AKT Ser473
phosphorylation
a) RICTOR-mTOR is necessary for AKT Ser473
phosphorylation induced by b1 integrins. It has been
shown that RICTOR-mTOR (TORC2) can directly interact
with AKT and phosphorylate Ser473, and it is widely accepted
that TORC2 is the principal AKT Ser473 kinase upon growth
factor stimulation. To elucidate the role of TORC2 in b1 integrin-
induced AKT Ser473 phosphorylation, we used siRNA directed
against RICTOR, the rapamycin-insensitive regulatory com-
ponent of this kinase complex. The effects of RICTOR knock-
down in HeLa and MCF7 cells were studied in cell adhesion assays
for 60 min on the b1 integrin-binding protein invasin. The
RICTOR siRNA efficiently reduced RICTOR protein levels in
both cell lines and suppressed integrin-induced AKT phos-
phorylation at Ser473 (Fig. 1A and 1B). Phosphorylation of the
AKT substrate FOXO1 at Thr24 was minimal in HeLa and
MCF7 cells seeded in non-adhesive (Pluronic-coated) dishes, and it
was strongly stimulated in the control-transfected cells attached to
invasin. In cells transfected with RICTOR siRNA, invasin-
induced FOXO1 Thr24 phosphorylation was reduced by 72%
in HeLa cells, and in MCF7 its level was close to the level seen in
non-adherent cells. The b1 integrin-induced phosphorylation of
BAD Ser136, an AKT substrate regulating apoptosis, was also
reduced after RICTOR knockdown in both cell lines.
Interestingly, the BAD Ser136 phosphorylation was maintained
at a higher level than FOXO1 Thr24 phosphorylation in non-
adherent cells during the assay period (Fig. 1A and 1B). As
expected, RICTOR knockdown did not affect b1 integrin-induced
ERK1/2 phosphorylation. These data demonstrate that
RICTOR-mTOR is the primary PDK2 activated by b1 integrins.
b) ILK is not required for b1 integrin-mediated AKT
Ser473 phosphorylation. The requirement for ILK in b1
integrin-induced phosphorylation of AKT Ser473 was tested in
HeLa and MCF7 cells. As shown in Fig. 1C, transfection of ILK-
directed siRNA in HeLa cells resulted in efficient suppression of
the protein (Fig. 1C). However, this did not affect the level of b1
integrin-induced AKT phospho-Ser473 (pSer473) during adhesion
to invasin or collagen type I. Similar results were obtained for
MCF7 cells (data not shown). Thus, while ILK is known to
mediate important integrin functions [34,35,36], it was
dispensable both as a kinase and an adaptor for AKT Ser473
phosphorylation. Consistent with this result, the b1 integrin-
induced phosphorylation of FOXO1 Thr24 and BAD Ser136 was
not affected by ILK knockdown (Fig. 1C).
c) PAK1 and PAK2 suppression does not affect b1 integrin-
mediated AKT Ser473 phosphorylation. Group I PAKs
(PAK1, PAK2 and PAK3) are of central importance during cell
growth and migration [37]. PAK has also been reported to
regulate RAC-dependent AKT activation [30,32], and PAK-
induced colon cancer cell survival and invasion require the PI3K-
AKT pathway [31]. To investigate whether PAK is needed for b1
integrin-mediated AKT Ser473 phosphorylation or not, we
simultaneously knocked down both PAK1 and PAK2 using
siRNAs. According to previous studies, knocking down both
isoforms is necessary in order to affect cell-signalling cascades
involving PAK [38]. Adhesion assays performed with PAK1/
PAK2-depleted cells revealed that these proteins were not required
for b1 integrin-mediated phosphorylation of AKT Ser473 or of
FOXO1 Thr24. Despite efficient knockdown of both PAK1 and
PAK2, the adhesion-induced phosphorylation levels at these sites
were comparable in non-target siRNA- and PAK1/PAK2 siRNA-
transfected cells (Fig. 1D and 1E).
Our attempts to confirm the data obtained from PAK1/PAK2
siRNA experiments using the PAK inhibitor IPA3 were not
successful. HeLa and MCF7 cells treated with 20 mM or higher
concentrations of IPA3 were unable to spread on invasin.
Interestingly, when added to already adherent HeLa and MCF7,
IPA3 was well tolerated at concentrations up to 50 mM and cells
did not show signs of distress or increased detachment from the
surface (data not shown).
d) b1 integrins induce Ser473 phosphorylation on both
AKT1 and AKT2 isoforms. So far, it is not known whether b1
integrins mediate Ser473 phosphorylation of all AKT family
members or just of a certain AKT isoform. A previous study by
Dufour et al. [39] reported that suspension culture of Caco-2/15
epithelial cells in serum-free medium for 24 h caused reduced
levels of pSer473 on AKT1 and AKT2, and b1 integrin-blocking
antibodies could also reduce AKT1 pSer473. In order to more
directly elucidate the isoform specificity of b1 integrin-triggered
AKT Ser473 phosphorylation, we performed adhesion assays
using MCF7 cells on the b1 integrin-specific ligand invasin
Regulation of AKT Ser473 Phosphorylation
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e32081Figure 1. RICTOR knockdown reduces b1 integrin-induced AKT Ser473 phosphorylation but ILK or PAK knockdown has no effect.
(A) HeLa cells were transfected with siRNA directed against RICTOR and then allowed to adhere to plates coated with invasin (b1 integrin-ligand) or
Pluronic (non-adhesive control) for 60 min. Cell lysates were subjected to SDS-PAGE (4–15% gradient gel) followed by western blotting using the
different antibodies as indicated. A representative western blot is shown and quantifications of AKT pSer473, FOXO1 pThr24, and BAD pSer136 on
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AKT2. AKT3 is not expressed at measurable protein and mRNA
levels in MCF7 and HeLa cells [40], and therefore an anti-AKT3
antibody was used as a control. Analysis of the efficiency of the cell
lysis conditions used for immunoprecipitation (Triton X-100 based)
showed that the pellet fraction obtained after centrifugation of the
cell lysate did not contain detectable amounts of AKT pSer473
(Fig. 2A), and thus most of the phosphorylated AKT after b1
integrin-stimulation was present in the soluble fraction (Fig. 2A).
While both AKT1 and AKT2 were phosphorylated at Ser473 in
response to adhesion, phosphorylation of AKT2 was clearly more
induced compared to AKT1 (Fig. 2B).
e) Adhesion-dependent signals improve cell survival
through RICTOR-mTOR activity. In adhesion-dependent
cells, integrin-induced survival signals are required to avoid
anoikis [41]. The importance of AKT activity and several of its
direct and indirect targets in cell survival is well documented
[42,43]. However, less is known about the contribution of the
Ser473 phosphorylation to AKT’s pro-survival functions.
After identification of RICTOR-mTOR as the primary PDK2
downstream of b1 integrins, we investigated the outcome of
RICTOR knockdown on integrin-mediated cell survival. Adhe-
sion-mediated protection against apoptosis was determined in
MCF7 cells, transfected with non-targeting or RICTOR siRNA,
by keeping them in starvation medium. After seeding on glass in
complete medium for 48 h, followed by 24 h of serum starvation,
the TUNEL assay revealed a 2-fold difference (p,0.05) in the
number of apoptotic cells between control and RICTOR-depleted
cells (9.6% versus 19.6%, Fig. 3A and 3B). To investigate the
contribution of b1 integrin-specific ligands to cell survival, non-
target or RICTOR-directed siRNA transfected MCF7 cells were
seeded in serum-free conditions on glass coated with invasin or
collagen type I. In the above-mentioned TUNEL experiments, the
presence of pyknotic nuclei, detected by DAPI staining, exactly
overlapped with the TUNEL staining (Fig. 3A). Counting of the
pyknotic nuclei after DAPI staining revealed that apoptosis was
significantly higher in RICTOR siRNA transfected cells on both
invasin (2-fold) and collagen type I (1.5-fold; Fig. 3C). To confirm
this finding through an alternative approach, the number of viable
cells was determined using the Trypan blue exclusion method.
After adhesion on collagen type I in serum-free medium, the
number of viable cells decreased more rapidly in the RICTOR
siRNA transfected cells than in control cells: after 24 h, 69% of the
cells were alive in the RICTOR-suppressed cells compared to 81%
in the control cells and after 48 h the corresponding values were
31% and 47% (Fig. 3D and E).
To investigate whether Ser473 phosphorylation affected the
adhesive functions of integrins, and thereby indirectly caused
reduced survival by disturbing other integrin signalling pathways,
cell attachment and spreading assays were performed. RICTOR
knockdown in HeLa cells had no visible influence on the cell
morphology after spreading on invasin, collagen type I or
vitronectin (Fig. S1A), and neither did it affect HeLa cell
attachment to these integrin ligands after 15 and 30 minutes
(Fig. S1B).
Integrins receptors versus cytokine receptors – common
features and differences
a) Role of RICTOR-mTOR and PAK in LPA-stimulated
AKT Ser473 phosphorylation. Analysis of the AKT Ser473
Figure 2. b1 integrins induce Ser473 phosphorylation on both AKT1 and AKT2. Adhesion assays were performed using MCF7 cells and
plates coated with Pluronic or invasin followed by immunoprecipitation with isoform-specific AKT1, AKT2 and AKT3 antibodies. (A) The lysates were
centrifuged in order to remove the insoluble fraction. The resulting pellet was investigated for the presence of AKT pSer473 by SDS-PAGE and
western blotting. A sample of each lysate supernatant after centrifugation was investigated for the presence of AKT pSer473, AKT1 and AKT2
proteins. (B) Immunoprecipitation was performed with antibodies specific for AKT1, AKT2 or AKT3 (included as control) in pre-cleared lysates. The
precipitates were boiled and subjected to two parallel SDS-PAGE and western blot analyses in order to detect total AKT or AKT pSer473 protein. In
spite of using light-chain specific anti-rabbit-HRP conjugates, some weaker unspecific bands (marked with an *) are visible due to interaction of the
primary western antibodies with the heavy chain of the IgGs used for immunoprecipitation.
doi:10.1371/journal.pone.0032081.g002
Pluronic and invasin are given below (mean 6 s.e.m.; n=3; * represents p,0.005 and ** represents p,0.05). (B) MCF7 cells were transfected and
treated in the same manner as in (A). (C) HeLa cells transfected with ILK-directed siRNA or non-target siRNA were allowed to adhere to plates coated
with Pluronic, collagen type I or invasin. Cells were lysed and analysed as explained above. A representative western blot is shown and the graph to
the right shows quantification of AKT pSer473 levels on Pluronic and invasin (mean 6 s.e.m.; n=3). (D) HeLa cells were transfected simultaneously
with PAK1- and PAK2-directed siRNAs or non-target siRNA. Adhesion assays were performed on plates coated with Pluronic, invasin or collagen type I.
Cell lysates were subjected to SDS-PAGE (10% gel) followed by western blotting using the different antibodies as indicated. A representative western
blot is shown and the graph below presents quantification of AKT pSer473 levels on Pluronic and invasin (mean 6 s.e.m.; n=3). (E) Adhesion assay
with MCF7 cells transfected with PAK1- and PAK2-directed siRNAs or non-target siRNA, performed as described in (A).
doi:10.1371/journal.pone.0032081.g001
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differences from the integrins pathway. First, RICTOR
knockdown did not affect the AKT Ser473 phosphorylation in
response to LPA in HeLa cells (Fig. 4A), and neither did
knockdown of ILK (Fig. 4B). This result was confirmed by
knocking down RICTOR and ILK simultaneously (Fig. S2). In
contrast, in MCF7 cells, RICTOR suppression markedly reduced
LPA-mediated phosphorylation of AKT at Ser473 (Fig. 4C). In
Figure 3. Adhesion-induced RICTOR-mediated AKT Ser473 phosphorylation promotes cell-survival. (A) MCF7 cells transfected with
RICTOR-directed or non-target siRNA were grown on glass coverslips in complete culture medium for 48 h, then serum starved for 24 h. A TUNEL
assay was performed to visualise apoptotic cells and DAPI was used to stain nuclei. Images shown are representative of pictures taken in three
independent experiments. (B) Quantification of (A): Five fields were photographed and at least 400 cells were counted from each coverslip and data is
presented as fold change in the percentage of apoptotic cells (mean 6 s.e.m.; n=3, ** represents p,0.05). (C) MCF7 cells were transfected as
described in (A) and after culturing them for 48 h, the cells were trypsinised and 5610
5 cells were seeded in starvation medium on invasin- or
collagen type I-coated glass coverslips. The cells were incubated in starvation medium for 24 h, fixed, stained with DAPI and observed under a
fluorescent microscope. Cells with pyknotic nuclei (condensed and brightly blue-stained) were considered as apoptotic cells. The result is presented
as fold change (mean 6 s.e.m.; n=2, * represents p,0.005 and ** represents p,0.05). (D) MCF7 cells were transfected as explained above and
subsequently 1610
5 cells were seeded onto collagen type I-coated dishes in starvation medium. The cells were trypsinised after the indicated time
periods and the number of viable cells was counted using the Trypan blue exclusion method. The plot shows fold change in the percentage of viable
cells (mean 6 s.e.m.; n=2 and ** represents p,0.05) normalised to non-target transfected cells for each time point. The actual numbers of viable cells
are given in the table below.
doi:10.1371/journal.pone.0032081.g003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32081Figure 4. Effects of RICTOR, ILK or PAK knockdown on LPA-induced AKT Ser473 phosphorylation in HeLa and MCF7 cells. (A) HeLa
cells were transfected with RICTOR-directed siRNA or non-target siRNA and then stimulated with LPA (10 mM) for 20 minutes. Cell lysates were
subjected to SDS-PAGE (4–15% gradient gel) and LPA-induced AKT Ser473 phosphorylation was determined by western blotting. A representative
western blot is shown and the graph below provides quantification of AKT pSer473 (mean 6 s.e.m.; n=3). (B) HeLa cells transfected with ILK-directed
siRNA and stimulated by LPA were analysed as described above. The graph below shows quantification of AKT pSer473 (mean 6 s.e.m.; n=2). (C)
MCF7 cells transfected as indicated were stimulated with LPA (5 mM) for 5 min and analysed as described above. A representative western blot is
presented and the graph below shows quantified levels of AKT pSer473 (mean 6 s.e.m.; n=3, * represents p,0.005). (D) MCF7 cells were transfected
simultaneously with PAK1 and PAK2 siRNA or with non-target siRNA and then stimulated with LPA (5 mM) for 5 min. A representative western blot is
shown. The graph below is a quantification of AKT pSer473 levels (mean 6 s.e.m.; n=3, ** represents p,0.05). (E) HeLa cells were treated with
increasing concentrations of the PAK inhibitor IPA3 or with DMSO and then stimulated with LPA (10 mM) for 20 min. The graph below is the
Regulation of AKT Ser473 Phosphorylation
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remained essentially unaffected. HeLa and MCF7 cells also
exhibited different kinetics in the response to LPA: MCF7 cells
gave maximum response when stimulated with 5 mM LPA for 3–
5 min (Fig. S3A), while HeLa cells required LPA stimulation for
20 min (Fig. S3B) to obtain detectable AKT Ser473 phospho-
rylation. Since HeLa and MCF7 cells express different LPA
receptors [44,45], our results suggest that distinct members of this
G protein-coupled receptor family use different mechanisms for
AKT activation.
Second, in contrast to b1 integrin-induced AKT Ser473
phosphorylation, the LPA-stimulated phosphorylation was de-
creased in MCF7 cells treated with PAK1/PAK2 siRNA (Fig. 4D).
This result was confirmed with the PAK inhibitor IPA3 in HeLa
cells as shown in Fig. 4E. A reduction in AKT pSer473 was seen in
cells treated with 20 mM IPA3, and no further effect was obtained
at higher inhibitor concentrations. IPA3 treatment did not reduce
phosphorylation of PAK itself at Thr423/402. These data are in
agreement with the proposed model of PAK inhibition by IPA3,
where IPA3 stabilizes PAK in an inactive conformation that
prevents autophosphorylation at Thr423, but it does not inhibit
the phosphorylation of this site by exogenous kinases [46].
Interestingly, ERK1/2 phosphorylation in response to LPA
increased in cells treated with IPA3. This increase was IPA3
dose-dependent (Fig. 4E). A similar effect of IPA3 on basal ERK1/
2 phosphorylation has previously been observed [46].
b) PDGF and EGF receptors use different routes to AKT
Ser473 phosphorylation. Differences in the requirement for
PAK were found not only between b1 integrins and LPA
receptors, but also among growth factor receptors. PAK1/PAK2
knockdown reduced PDGF-stimulated AKT phosphorylation at
Ser473 in MCF7 cells (Fig. 5A) as previously reported for COS1
and NIH3T3 cells [30]. In contrast, it did not inhibit EGF-induced
AKT pSer473 in either MCF7 or HeLa cells (Fig. 5B). This
difference in PAK-dependency was not caused by the different
kinetics of Ser473 phosphorylation induced by PDGF or EGF
because it was present during the entire response period (Fig. S4A
and 4B). Consistent with the siRNA data, IPA3 inhibited
induction of AKT Ser473 phosphorylation by PDGF but not by
EGF (Fig. 5C).
Other features of the AKT Ser473 phosphorylation pathway
were similar for PDGF and EGF receptors as for b1 integrins:
RICTOR knockdown reduced AKT Ser473 phosphorylation
(Fig. 5D, E), and this phosphorylation event occurred indepen-
dently of ILK (Fig. 5F).
Discussion
Regulation of AKT activity is a tightly controlled event and its
importance is evident from the pathological states that emerge due
to the loss of this control. In particular, elevated levels of AKT
activity are linked to tumour progression and resistance to anti-
cancer treatments [47,48]. As an important part of AKT
regulation, several phosphorylation sites on AKT have evolved.
Most studied is the phosphorylation of Thr308 and Ser473, both
reactions being strongly induced by several types of stimuli and
used as markers for AKT activation. However, while phosphor-
ylation of Thr308 is strictly required for AKT kinase activity, the
role of pSer473 is still not fully understood. Three major functions
have been proposed for the latter phosphorylation site: a) It has
been reported to strongly promote binding of PDK1 to AKT, and
thereby to facilitate the subsequent activating phosphorylation of
Thr308 [16,49]. b) The serine-phosphorylated hydrophobic motif
may also interact intra-molecularly with the catalytic domain of
AKT and stabilize its activated state [50]. c) It may affect the
substrate specificity of AKT [25]. Notably, none of these functions
exclude the others.
Both PDK1 and PDK2 are dependent on 39-phosphorylated
membrane phosphatidylinositols for phosphorylation of AKT, and
we previously showed that b1 integrins use the p110a PI3K
catalytic subunit for the generation of such phospholipids [51].
Our primary aims for the present investigation were to clarify the
mechanism of AKT Ser473 phosphorylation during adhesion via
b1 integrins and to determine its contribution to adhesion-
mediated survival of cells. We used two human carcinoma cell
lines, the epithelial-like MCF7 and the mesenchymal-like HeLa,
which can efficiently be transfected with siRNA.
siRNA-mediated knockdown of the main PDK2 candidates,
TORC2 and ILK, revealed that TORC2, but not ILK, was
necessary for AKT Ser473 phosphorylation downstream of b1
integrins (Fig. 1A–C). Our experiments thus extend the existing
evidence about the RICTOR-mTOR complex as the principal
PDK2 downstream of growth factor receptors to also include b1
integrins. ILK has been shown to associate with b1 integrins [34]
and a large body of literature directly or indirectly implicates ILK
in AKT regulation and as a PDK2 [11,20,35,52,53]. However,
convincing evidence provided by other studies contradicts claims
made about ILK’s kinase functions [21,23] and concludes that it
performs important tasks as an accessory protein in several
signalling events. Depletion of ILK by siRNA or conditional
knockout were reported to cause reduced AKT Ser473 phosphor-
ylation in various cell lines, including MCF7 [20,52]. In contrast,
using siRNA-mediated knockdown, we could not establish a
function for ILK in b1 integrin-, EGF- or LPA-mediated AKT
Ser473 phosphorylation in HeLa and MCF7 cells. These
seemingly conflicting results most likely reflect the different assay
conditions used. In the previous studies, the cells were harvested
and analysed after several days of continuous growth in serum
without any specific stimuli, while acute stimulation of selected
receptors was used in the present study. Since ILK participates in
the regulation of basic cell functions such as focal contact assembly
and actin dynamics [35,36], the effects of ILK depletion on AKT
phosphorylation during long term experiments may conceivably
be indirect rather than targeting the actual AKT phosphorylation
mechanism. However, at present the possibility cannot be
excluded that ILK may have a scaffold function for AKT
activation downstream of a particular stimuli in a certain cell
type, but this remains to be demonstrated.
Immunoprecipitation with isoform-specific antibodies showed
that both AKT1 and AKT2 were phosphorylated on Ser473 in
response to adhesion. Notably, while the Ser473 phosphorylated
AKT1 and AKT2 migrated equally fast in SDS-PAGE, the main
pool of AKT2 migrated slightly faster than AKT1 (Fig. 2B). This
observation was made in three different cell lines, MCF7 (Fig. 2B),
HeLa and GD25 (data not shown) using two different AKT2
antibodies (Abcam, ab66129 and Santa Cruz, sc-81436), suggest-
ing that the shift in mobility, possibly caused by additional
modifications of AKT2, is commonly occurring during its
activation. AKT Ser473 phosphorylation was more pronounced
for AKT2 than AKT1 during spreading of MCF7 cells on invasin,
quantification of AKT pSer473 levels after LPA-stimulation in cells treated with IPA3 (30 mM) normalised to the pSer473 level of this protein in LPA-
stimulated cells without the inhibitor (mean 6 s.e.m.; n=3, * represents p,0.005).
doi:10.1371/journal.pone.0032081.g004
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prominent activation of AKT2 by b1 integrins is particularly
interesting in view of its reported localization to mitochondria in
MCF7 cells as well as several other cell lines [40]. Furthermore,
AKT2 was found to prevent autophagy of mitochondria and to
have a major role in protection against apoptosis [54]. It is
presently unknown whether AKT2 is activated at the plasma
membrane and subsequently translocated to the mitochondria or if
integrins can directly activate AKT2 residing on the mitochondria.
In adhesion-dependent cells, integrins promote cell survival
mainly through the PI3K-AKT pathway [1,2]. It is well
established that blocking integrin signals makes cells vulnerable
to apoptosis. Furthermore, Uesugi et al. [55] have recently
identified a microRNA, miR-218, that inhibits AKT Ser473
phosphorylation by reducing RICTOR protein levels. Their
findings that forced miRNA-218 expression in oral cancer cell
lines, lacking endogenous miRNA-218, can induce caspase-
mediated apoptosis in these cells, highlights the relevance of
RICTOR-regulated AKT activity to apoptosis protection. Our
studies demonstrated that RICTOR-dependent AKT Ser473
phosphorylation aids b1 integrins in protecting cells from cell
death under serum starvation conditions. This effect can at least
partly be ascribed to activation of the important anti-apoptotic
AKT target BAD, since b1 integrin-induced phosphorylation of
BAD Ser136 was reduced after RICTOR knockdown (Fig. 1A and
1B). Phosphorylation of BAD Ser136 prevents BAD from binding
to Bcl2, and thereby allows Bcl2 to inactivate the pro-apoptotic
BAX [56]. However, BAD pSer136 levels were relatively high in
HeLa and MCF7 cells after RICTOR knockdown compared to
the level of FOXO1 pThr24 (Fig. 1A and 1B). Phosphorylation of
FOXO1 Thr24 and a few other unidentified AKT substrates were
previously shown to be strongly dependent on TORC2-mediated
AKT phosphorylation at Ser473, while several other AKT
substrates were less affected by disruption of the TORC2 complex
[25]. Our data indicates that BAD belongs to the latter group of
AKT targets, and that the reduced BAD phosphorylation after
RICTOR knockdown reflects a general lower AKT activity rather
than involvement of phosphorylated Ser473 in recognition of BAD
as substrate. Another difference between BAD and FOXO was the
complete dephosphorylation of FOXO in non-adherent cells
within 2 hours (the total time the cells remained in suspension in
our adhesion assay, as explained in the methods section), while a
higher level of phosphorylated BAD was retained. Possibly, the
different turnover kinetics are due to the interaction of 14-3-3
proteins with BAD pSer136 [56].
LPA receptors, and several other members of the G protein-
coupled receptor family, can also activate the PI3K-AKT pathway
[57]. This activation involves the action of Gi, PI3K p110b and
PDK1 [58]. Our attempts to study the possible role of TORC2
downstream of LPA produced diverging results. In HeLa cells,
RICTOR knockdown, and even simultaneous RICTOR and ILK
knockdown, did not reduce LPA-generated AKT Ser473 phos-
phorylation (Fig. 4A and Fig. S2). In contrast, RICTOR
suppression did reduce Ser473 phosphorylation in MCF7 cells
(Fig. 4C). MCF7 cells mainly express the receptor LPA2 and some
LPA1 [45], while HeLa cells express receptor LPA3 in addition to
a lower level of LPA2 [44]. Possibly, these differences in the
available LPA receptors resulted in different responses after
RICTOR suppression, i.e. LPA3 may activate another AKT
hydrophobic-motif kinase. This reasoning is supported by our
observations that HeLa cells respond to LPA with much slower
kinetics (Fig. S3A), compared to MCF7 cells (Fig. S3B). However,
our data is insufficient to unambiguously connect the upstream
individual LPA receptors with specific PDK2s preferred for AKT
activation. Nevertheless, our results are consistent with the results
by Shiota et al. [26], which showed that alternative PDK2s exist
beside TORC2 since residual Ser473-phosphorylated AKT was
detected in RICTOR knockout mouse embryos.
A recent report by Higuchi et al. [30] has brought PAK’s role
in AKT activation into focus. They provide evidence that PAK is
involved in the PI3K-AKT pathway as a scaffolding protein.
Other studies also suggest a need for PAK in AKT activation
[28]. However, in our adhesion assays, PAK1/PAK2 knockdown
did not reduce b1 integrin-induced phosphorylation of AKT
Ser473 (Fig. 1D and 1E). These results are not in conflict with the
findings of Higuchi et al. [30] since their work focussed on the
role of PAK in growth factor-induced AKT activation. The
results of our experiments with PDGF were consistent with their
data (Fig. 5A).
Another case of PAK-independent AKT Ser473 phosphoryla-
tion was observed after EGF-stimulation in MCF7 and HeLa cells
(Fig. 5B and 5C). Nakamura et al. [59] have recently shown that
the EGF receptor uses Freud1/Aki1 as a PI3K and PDK1
scaffolding protein. However, Freud1 inhibition only reduced
phosphorylation at Thr308 and had no effect on Ser473. Thus,
while both PAK and Freud1/Aki1 are dispensable for AKT
Ser473 phosphorylation downstream of the EGF receptor, these
examples indicate that the use of scaffold proteins may be a
common feature in AKT activation by different receptors.
To conclude, we have provided evidence for a role of TORC2
as the PDK2 activated by b1 integrins, and that Ser473
phosphorylation of AKT1/2 significantly contributes to adhe-
sion-induced survival signals. Our data also highlights the
involvement of PAK in LPA and PDGF pathways to Ser473
phosphorylation and indicates the need for further in-depth studies
to elucidate the role of PAK, and possibly other scaffold proteins,
in AKT activation. A general finding of our study is that the
important phosphorylation reaction of AKT Ser473 is more
complex than depicted in current models and that the mechanism
varies depending on the stimulated receptor.
Figure 5. PAK is necessary for PDGF but not for EGF-mediated AKT Ser473 phosphorylation whereas RICTOR knockdown inhibits
both pathways. (A) PAK1 and PAK2 expression was suppressed in MCF7 cells using siRNAs and the cells were stimulated with 20 ng/ml PDGF-BB for
10 min. A representative western blot is shown and AKT pSer473 is quantified below (mean 6 s.e.m.; n=2, ** represents p,0.05). (B) MCF7 and HeLa
cells were transfected as above and stimulated with 20 ng/ml EGF. A representative western blot is shown and below quantification of AKT pSer473
in MCF7 and HeLa cells (mean 6 s.e.m.; n=3) is presented. (C) HeLa cells were treated with PAK inhibitor IPA3 (30 mM) or DMSO as vehicle control
and then stimulated with 20 ng/ml PDGF-BB or EGF. A representative western blot is shown. The graph provides quantification of AKT pSer473 levels,
after EGF-stimulation of cells treated with IPA3 (30 mM) normalised to the pSer473 level of this protein in EGF-stimulated cells without the inhibitor
(mean 6 s.e.m.; n=3). (D) RICTOR expression was suppressed in HeLa cells using siRNA and the cells were stimulated with EGF (20 ng/ml). Cell lysates
were subjected to SDS-PAGE followed by western blotting using antibodies as indicated. A representative blot is shown and quantification of AKT
pS473 levels is found below (mean 6 s.e.m.; n=3, ** represents p,0.05). (E) HeLa cells transfected with RICTOR-directed siRNA were stimulated with
20 ng/ml PDGF-BB and analysed as in (D). A representative western blot is shown and the graph below shows quantification of AKT pSer473 (mean 6
s.e.m.; n=2, * represents p,0.005). (F) HeLa cells, transfected with non-target or ILK-directed siRNA, were stimulated with 20 ng/ml EGF and the
samples analysed as explained above. The graph shows quantification of AKT pSer473 (mean 6 s.e.m.; n=2).
doi:10.1371/journal.pone.0032081.g005
Regulation of AKT Ser473 Phosphorylation
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e32081Materials and Methods
Cells
HeLa and MCF7 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, GIBCO Invitrogen) containing 10%
fetal bovine serum, penicillin-streptomycin and fungizone. All
experiments were performed with cells in log-phase growth.
Antibodies, siRNAs and other reagents
The following antibodies used in this study were from Cell
Signaling Technology, USA: anti-AKT pSer473 (#9271), anti-
pERK1/2 (#9106), anti-PAK1(pThr423)/PAK2(pThr402)
(#2601), anti-PAK1 (#2602), anti-PAK2 (#2608), anti-AKT3
(#3788), anti-total AKT (#9272), anti-FOXO1 pThr24/
FOXO3a pThr32 (#9464), anti-BAD pS136 (#4366). AKT1
antibody (ab6076) was bought from Abcam, anti-RICTOR
(A300-459A) from Bethyl, USA, and anti-AKT2 (sc-81436), anti-
ILK (sc-7516), HRP-conjugated anti-actin (sc-1616) and HRP-
conjugated donkey anti-goat secondary antibody (sc-2020) were
from Santa Cruz Biotechnologies. HRP-conjugated donkey anti-
rabbit (NA9340) and HRP-conjugated sheep anti-mouse
(NA9340) were from GE Healthcare, UK. Light-chain specific
mouse-anti-rabbit peroxidase (211-032-171) was from Jackson
Immuno Research, Protein A/G PLUS agarose (sc-2003) from
Santa Cruz and Sepharose 4B from Pharmacia. The ECL kit
(#RPM2106) was from GE Healthcare, Uppsala. The siRNAs
against RICTOR, ILK, PAK1, PAK2 and a non-target siRNA
were from Thermo Scientific (Dharmacon, siGENOME SMART-
pool). All siRNAs were diluted in siRNA buffer (Dharmacon) to
20 mM stock solutions, which were aliquoted and stored at 220uC.
The siRNA transfections were performed using Ingenio
TM
electroporation solution (MirusBio, USA) and AMAXA Nucleo-
fectorH (Lonza, USA). Group-I PAK inhibitor IPA3, fatty acid-
free BSA and lysophosphatidic acid (LPA) sodium salt were
purchased from Sigma. IPA3 stock solution (14 mM) was prepared
in cell culture grade DMSO (Sigma). LPA stock solution (2.3 mM)
was prepared in chloroform:methanol:acetic acid (95:5:5). Bovine
dermal collagen type I was from Cellon, Luxembourg. The Click-
iTH TUNEL assay kit (#C10245) was obtained from Invitrogen.
siRNA transfections
Two days before transfection, the cells were sub-cultured in
order to obtain around 80% confluence on the day of transfection.
The cells were washed with PBS and detached from the flask
surface by trypsin-EDTA treatment for 15 min at 37uC. Trypsin
was inactivated by serum-supplemented medium and the cells
were counted. The optimised transfection protocols for HeLa and
MCF7 cell lines recommended by Lonza were used. Briefly, each
transfection was performed with 5610
5 HeLa and 2610
6 MCF7
cells. The respective cell pellet was re-suspended in 100 mlo f
Ingenio
TM transfection reagent and the required siRNA against
RICTOR, ILK, PAK1 or PAK2 was mixed with the cell
suspension. A control reaction using non-target siRNA was also
included. The transfected cells were allowed to grow for 48–72 h
before further experiments.
Adhesion assay
Signal transduction reactions generated by b1 integrins were
studied in cell adhesion experiments on invasin-, collagen type I-
or Pluronic-coated wells of six-well cell culture plates as reported
previously [33]. Briefly, after coating with integrin ligands, any
remaining uncoated plastic surface was blocked with Pluronic.
Cells were serum-starved over-night and then harvested with
trypsin-EDTA. Trypsin was inactivated with soybean trypsin
inhibitor; the cells were washed and then allowed to rest in
suspension for one h at 37uC. Subsequently, they were seeded and
allowed to adhere for 60 min at 37uC. The plates were put on ice
and the medium including non-attached cells was collected and
centrifuged. The resulting cell pellet was then combined with the
lysate from adherent cells of the corresponding well, which was
harvested by scraping the well with SDS-PAGE sample buffer
(SDS-SB). The lysates were analysed by SDS-PAGE followed by
western blotting.
Immunoprecipitation
MCF7 cells were serum-starved over-night and adhesion assays
were performed in tissue culture plates (10 cm diameter) coated
with invasin or Pluronic as described above. One h after seeding
the cells, the non-attached cells were collected and centrifuged at
4uC. In the meanwhile, Triton-lysis buffer (16TBS, Roche
complete Mini protease inhibitor cocktail, 1% Triton X-100,
200 mMN a 3VO4, 125 mM NaF) was added to the plates on ice
and the adherent cells were lysed and scraped. These lysates were
combined with the corresponding pellets after the centrifugation
and then incubated end-over-end in the cold for 20 min. ‘‘Total
lysate’’ samples were taken out and boiled with SDS-SB before the
remaining lysate was centrifuged at 160006g for 10 min at 4uCt o
remove Triton-insoluble material. The resulting supernatant was
pre-cleared with a mixture of Sepharose 4B and protein A/G
agarose for at least 30 min at 4uC and the pellets were boiled with
SDS-SB as ‘‘pellet control’’. After the pre-clearing, AKT isoform-
specific antibodies were added according to the manufacturer’s
recommendation and incubated end-over-end for one h. This was
followed by one h incubation with protein A/G agarose end-over-
end at 4uC. Finally, the agarose pellets were washed three times
with wash buffer (PBS; 0.1% Triton X-100, Roche Mini protease
inhibitor cocktail, 200 mMN a 3VO4, 125 mM NaF) and then
boiled in SDS-SB. During the subsequent western blot analysis,
light-chain specific anti-rabbit HRP secondary antibodies were
used to avoid disturbance by the primary IgG heavy chains.
PDGF-BB-, EGF- and LPA-stimulation
All the experiments involving PDGF-BB-, EGF- and LPA-
stimulation of cells were performed on cells grown in a six-well cell
culture plate. Prior to stimulation, the cells were starved in serum-
free DMEM for 24 h. PDGF-BB and EGF stimulation reactions
were carried out for 10 min using 20 ng/ml of each growth factor.
For LPA stimulation, the required volume of LPA was transferred
to an Eppendorf tube and the solvent (chloroform, methanol,
acetic acid) was evaporated under nitrogen gas. LPA was re-
constituted in PBS containing 1 mg/ml fatty acid-free BSA and
added to the cells kept in fatty acid-free BSA-containing starvation
medium. HeLa and MCF7 cells were stimulated with 10 mM and
5 mM LPA, respectively, in order to obtain maximal responses.
Inhibitor treatment
The stock solution of PAK inhibitor IPA3 was prepared as
described under reagents. The desired working dilution of this
inhibitor was prepared directly in starvation medium. Equally
diluted DMSO was used as control. Starved cells (24 h) were
treated with either the inhibitor or DMSO for 30 min and then
used for further experiments.
SDS electrophoresis and western blotting
Proteins were resolved on pre-cast polyacrylamide mini gels
(BioRad) after reduction with 50 mM DTT and then transferred
to Hybond-ECL nitrocellulose membrane (GE Healthcare, UK).
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containing 0.1% Tween 20 (TBS-T). All primary antibody
incubations were carried out at 4uC over-night. All secondary
antibody incubations were performed at room temperature for one
h. The membranes were incubated with ECL substrate, and the
signals were detected using x-ray films.
Determination of apoptosis using Trypan blue exclusion,
TUNEL and DAPI staining
Cell viability during serum starvation was determined in cells
transfected with siRNA against RICTOR and non-target siRNA,
respectively. After transfection, the cells were grown for 48 h
followed by trypsin-EDTA treatment and seeding onto collagen-
coated dishes at a density of 1610
5 cells per dish in starvation
medium. Subsequently, cell viability was determined after 12, 24
and 48 h by the Trypan blue exclusion method.
Serum starvation-induced apoptosis was determined using
TUNEL and DAPI staining. Cells transfected as described above
were grown on glass cover slips for 48 h in complete medium and
then incubated in serum-free starvation medium for 24 h. DNA
breaks were detected using a TUNEL assay kit (Invitrogen)
according to the manufacturer’s protocol. Slides were viewed
under a fluorescent microscope (Nikon, ECLIPSE 90i) and bright
green coloured cells were considered as apoptotic cells. Alterna-
tively, MCF7 cells were transfected and grown in complete culture
medium for 48 h before they were trypsinised, and 500,000 cells
were seeded onto glass cover slips coated with invasin (20 mg/ml)
or collagen type I (50 mg/ml). After incubation in starvation
medium for 24 h the cells were fixed with methanol, stained with
DAPI, and observed under a fluorescent microscope. Cells with
condensed, brightly blue-stained pyknotic nuclei were considered
as apoptotic cells.
Statistical analysis
Student t-test was used to determine statistical importance of the
data. A p value ,0.05 was considered statistically significant, and
in the figures one asterisk (*) represents p,0.005 and ** represents
p,0.05.
Supporting Information
Figure S1 (A) Morphology of HeLa cells transfected with
either non-target or RICTOR siRNA after 30 min of
spreading on the indicated substrates at 376C. (B)
Attachment assay with HeLa cells transfected with either non-
target or RICTOR siRNA. The cells were essentially treated as
described under the adhesion assay heading in the Materials and
Methods section. 20,000 serum-starved cells per well were seeded
in invasin-, collagen-, vitronectin- or Pluronic-coated wells of a 96-
well plate and allowed to attach for 15 or 30 min at 37uC. Non-
attached cells were removed and the remaining cells were fixed
with 96% ethanol for 10 min. Cells were stained for 20 min with
0.1% crystal violet and solubilised in 0.5% SDS. Absorbance was
measured at 600 nm.
(TIF)
Figure S2 Simultaneous knockdown of RICTOR and
ILK does not reduce LPA-mediated AKT Ser473 phos-
phorylation in HeLa cells. The cells were transfected with
RICTOR- and ILK-directed siRNAs simultaneously or with non-
target control siRNA and then stimulated with LPA (10 mM) for
20 min. Knockdown efficiency of RICTOR and ILK, and the
phosphorylation status of AKT at Ser473 were analysed by
western blotting.
(TIF)
Figure S3 The kinetics of LPA-induced AKT Ser473
phosphorylation are different in HeLa and MCF7 cells
(A) HeLa cells were serum-starved and stimulated with LPA
(10 mM) for different time periods as indicated. (B) Serum-starved
MCF7 cells were stimulated with LPA (5 mM).
(TIF)
Figure S4 PAK knockdown inhibits PDGF-mediated
AKT pSer473, but does not affect kinetics of EGF-
induced AKT pSer473. MCF7 cells were transfected simulta-
neously with PAK1- and PAK2-directed siRNAs or non-target
siRNA, grown in complete culture medium for 48 h, serum-
starved for 24 h and then stimulated with 20 ng/ml PDGF-BB (A)
or 20 ng/ml EGF (B) for the indicated time periods. The efficiency
of PAK1 and PAK2 knockdown and the effect of PAK suppression
on AKT pSer473 were analysed by western blot.
(TIF)
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